|Impaired left ventricular diastolic function and vascular postischemic vasodilation associated with microalbuminuria in IDDM patients.|
|PMID: 7555479 Owner: NLM Status: MEDLINE|
|OBJECTIVE: Microalbuminuria is considered an important predictor of cardiovascular events in diabetic patients. In this study, a possible association of microalbuminuria with significant changes in left ventricular (LV) morphology and function and generalized vascular dysfunction was analyzed in insulin-dependent diabetes mellitus (IDDM) patients without hypertension, coronary artery disease, or autonomic dysfunction. RESEARCH DESIGN AND METHODS: Thirty-four young long-term IDDM patients, 16 with and 18 without microalbuminuria, and 20 control subjects were studied. LV systolic function and wall thickness were evaluated by M-mode echocardiography. LV diastolic function was studied using a combined echo-Doppler and phonocardiographic technique. The hyperemic response to forearm ischemia was measured by strain-gauge plethysmography. All patients underwent 24-h ambulatory blood pressure monitoring. RESULTS: LV mass index and wall thickness:radius ratio were significantly higher in microalbuminuric patients. LV relaxation was significantly impaired in both diabetic groups compared with control subjects; moreover, this impairment was significantly greater in microalbuminuric than in normoalbuminuric patients. In microalbuminuric patients, forearm postischemic vasodilation was also significantly lower and mean awake diastolic blood pressure (dBP) was significantly higher than in the other two groups. CONCLUSIONS: Our data suggest that microalbuminuria is associated with significant changes in LV morphology, a more severe impairment of cardiac diastolic function, altered vascular dilatory capacity, and higher daytime dBP. Therefore, microalbuminuric patients should be considered to have a higher risk of cardiovascular complications and be kept under closer surveillance.|
|M D Guglielmi; S D Pierdomenico; L Salvatore; F Romano; E Tascione; M Pupillo; E Porreca; T Imbastaro; F Cuccurullo; A Mezzetti|
Related Documents :
|17409109 - Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in pa...
17495269 - Afterload reduction may halt and beta-adrenergic blockade may worsen progression of lef...
19593939 - Acute effect of transcatheter closure on right ventricular function in patients with at...
10669669 - Left ventricular thrombus and subsequent thromboembolism in patients with severe systol...
11315119 - Factor v leiden and its relation to left ventricular thrombus in acute myocardial infar...
19833379 - Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients w...
9392049 - Cervical spondylosis in paraplegic patients and analysis of the wheelchair driving acti...
7831679 - Prothrombin fragment f 1 + 2 and oral anticoagulant therapy.
22572859 - Activated innate immunity and the involvement of cx3cr1-fractalkine in promoting hematu...
|Type: Comparative Study; Journal Article|
|Title: Diabetes care Volume: 18 ISSN: 0149-5992 ISO Abbreviation: Diabetes Care Publication Date: 1995 Mar|
|Created Date: 1995-11-21 Completed Date: 1995-11-21 Revised Date: 2010-03-24|
Medline Journal Info:
|Nlm Unique ID: 7805975 Medline TA: Diabetes Care Country: UNITED STATES|
|Languages: eng Pagination: 353-60 Citation Subset: IM|
|Centro per lo Studio e la Terapia dell'Ipertensione Arteriosa, Istituto di Fisiopatologia Medica, Chieti, Italy.|
|APA/MLA Format Download EndNote Download BibTex|
Diabetes Mellitus, Type 1 / complications, physiopathology*, urine
Diabetic Angiopathies / physiopathology*
Diabetic Retinopathy / epidemiology, physiopathology
Forearm / blood supply
Hemoglobin A, Glycosylated / analysis
Ischemia / physiopathology*
Regional Blood Flow
Ventricular Dysfunction, Left / physiopathology*
|0/Hemoglobin A, Glycosylated|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Trial of pentoxifylline for diabetic impotence.
Next Document: Implementation of treatment protocols in the Diabetes Control and Complications Trial.